|
Boster Bio
anti zbp1 Anti Zbp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2BP1+Antibody/pmc13006297-220-20-27 Average 93 stars, based on 1 article reviews
anti zbp1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
igf1 inhibitor xentuzumab Igf1 Inhibitor Xentuzumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Xentuzumab/pm38759655-442-5-8 Average 92 stars, based on 1 article reviews
igf1 inhibitor xentuzumab - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Boster Bio
primary antibodies against α sma Primary Antibodies Against α Sma, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2%2FIGF+II+Rabbit+Monoclonal+Antibody/pm41606740-82-1-7 Average 94 stars, based on 1 article reviews
primary antibodies against α sma - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Atlas Antibodies
rabbit polyclonal anti igf ii antibody ![]() Rabbit Polyclonal Anti Igf Ii Antibody, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2/pmc05820043-57-4-8 Average 86 stars, based on 1 article reviews
rabbit polyclonal anti igf ii antibody - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Boster Bio
r es ama1 ![]() R Es Ama1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2BP1+Antibody/pmc09623944-83-2-15 Average 94 stars, based on 1 article reviews
r es ama1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Boster Bio
igf2 ![]() Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF-2+Reference+Antibody/pmc08303261-9-0-10 Average 90 stars, based on 1 article reviews
igf2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Boster Bio
igf 2r ![]() Igf 2r, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2R+(Phospho-Ser2484)+Antibody/pmc03503720-123-8-15 Average 90 stars, based on 1 article reviews
igf 2r - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedImmune llc
monoclonal antibodies against igf-1 and igf-2 ![]() Monoclonal Antibodies Against Igf 1 And Igf 2, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/fully+human+mab+anti++igf1+and++igf2/pmc08892134-105-6-11 Average 90 stars, based on 1 article reviews
monoclonal antibodies against igf-1 and igf-2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GeneTex
anti-igf2 gtx60630 ![]() Anti Igf2 Gtx60630, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/anti+igf2+gtx60630/pmc06441876-80-28-29 Average 90 stars, based on 1 article reviews
anti-igf2 gtx60630 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Kirin Holdings Company Limited
anti-igf2 neutralizing antibody ![]() Anti Igf2 Neutralizing Antibody, supplied by Kirin Holdings Company Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/anti+igf2+neutralizing+antibody/10__2147_slash_ott__s211043-30-0-7 Average 90 stars, based on 1 article reviews
anti-igf2 neutralizing antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Boster Bio
rabbit anti igf2 ![]() Rabbit Anti Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/Anti-IGF2-AS+Antibody+Picoband/pm32882328-109-8-11 Average 90 stars, based on 1 article reviews
rabbit anti igf2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Creative Biolabs
anti human muc1 therapeutic antibody fab fragment ![]() Anti Human Muc1 Therapeutic Antibody Fab Fragment, supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/anti+human+igf1+igf2+monoclonal+therapeutic/pmc13020000-78-0-10 Average 86 stars, based on 1 article reviews
anti human muc1 therapeutic antibody fab fragment - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Internal Medicine
Article Title: A Hypoglycemia-inducing Giant Borderline Phyllodes Tumor Secreting High-molecular-weight Insulin-Like Growth Factor II: Immunohistochemistry and a Western Blot Analysis
doi: 10.2169/internalmedicine.9287-17
Figure Lengend Snippet: The microscopic findings [Hematoxylin and Eosin (H&E) staining and immunohistochemical staining of the resected tumor]. H&E staining (A) Low-power (×40) and (B) high-power (×400) views showed moderate stromal hypercellularity with mild nuclear atypia and mild pleomorphism of the spindle cells. Focal mildly atypical epithelial hyperplasia was also noted. Stromal overgrowth was absent. Immunohistochemical staining of (C) the phyllodes tumor and (D) normal breast tissue using rabbit polyclonal anti-insulin-like growth factor II (IGF-II) antibodies. The tumor cells, but not the normal breast tissue, were diffusely immunopositive for IGF-II.
Article Snippet: They were probed with
Techniques: Staining, Immunohistochemical staining
Journal: Internal Medicine
Article Title: A Hypoglycemia-inducing Giant Borderline Phyllodes Tumor Secreting High-molecular-weight Insulin-Like Growth Factor II: Immunohistochemistry and a Western Blot Analysis
doi: 10.2169/internalmedicine.9287-17
Figure Lengend Snippet: Western blotting of high-molecular-weight IGF-II. Lane 1, serum from a healthy control; lane 2, serum from the patient collected preoperatively; lane 3, serum obtained 3 days after the resection of the tumor; lane 4, phyllodes tumor tissue. Large amounts of high-molecular-weight IGF-II were detected in the serum collected preoperatively (lane 2) and in the tumor tissue (lane 4) but not in serum collected postoperatively (lane 3) or a serum sample from a healthy control (lane 1).
Article Snippet: They were probed with
Techniques: Western Blot, High Molecular Weight, Control
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Trial design and vaccine procedures
Article Snippet: The separated
Techniques: Infection, Sterility, Injection
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Multiple sequence alignments of IMP1 and AMA1 from different species. a Multiple alignment of E. stiedae IMP1 with IMP1 proteins from other parasites: Eimeria maxima (UniProt: F4MKA6), Eimeria acervulina (UniProt: U6GHD9), Eimeria tenella (UniProt: F4MKA7), Eimeria mitis (UniProt: U6JVY4), Eimeria praecox (UniProt: U6GBP2); ( b ) multiple alignment of E. stiedae AMA1 with AMA1 proteins from other parasites: Eimeria tenella (UniProt: U6KTA0), Eimeria brunetti (UniProt: U6LBB9), Toxoplasma gondii (UniProt: B6KAM0), Besnoitia besnoiti (UniProt: A0A2A9MBX4), Neospora caninum (UniProt: F0VH85); Blue shading indicates conserved residues. Dashed red boxes represent B-cell epitopes. The transmembrane region is marked with a solid red box
Article Snippet: The separated
Techniques: Sequencing
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: SDS-PAGE and Western blotting analysis of r Es IMP1 ( a ) and r Es AMA1 ( b ). Lane M: Protein molecular weight markers; lanes 1–4: recombinant proteins that were dissolved in the supernatant, 4 M urea, 6 M urea, and 8 M urea after ultrasonication; lane 5: purified recombinant proteins; lane 6: purified recombinant proteins incubated with anti- E. stiedae positive sera; lane 7: purified recombinant proteins incubated with negative sera from coccidia-free rabbits (the bands are indicated using arrows)
Article Snippet: The separated
Techniques: SDS Page, Western Blot, Molecular Weight, Recombinant, Purification, Incubation
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Protective effects of r Es AMA1 and r Es IMP1 against E. stiedae infection under different evaluation indicators
Article Snippet: The separated
Techniques: Infection
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Gross postmortem examinations of the liver. a PBS-uninfected group; ( b ) PBS-infected group; ( c ) Quil-A-infected group; ( d ) Trx-His-S-infected group; ( e ) r Es AMA1 group; ( f ) r Es IMP1 group
Article Snippet: The separated
Techniques: Infection
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Biochemical estimation of ALT and AST levels in the six groups
Article Snippet: The separated
Techniques:
Journal: Parasites & Vectors
Article Title: Preliminary evaluation of the protective effects of recombinant AMA1 and IMP1 against Eimeria stiedae infection in rabbits
doi: 10.1186/s13071-022-05492-4
Figure Lengend Snippet: Changes in serum antibody levels. The changes in serum anti-r Es IMP1 ( a ) and r Es AMA1 ( b ) antibody levels after the first vaccination (week 0, indicated by arrows), booster vaccination (week 2, indicated by arrows), and infection with E. stiedae (week 4, indicated by an arrow)
Article Snippet: The separated
Techniques: Infection
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Primers sequences for qPCR.
Article Snippet:
Techniques: Amplification
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Antibodies used for Western blot.
Article Snippet:
Techniques: Western Blot
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens transcripts in the whole thymus. Complementary DNA obtained from mock- and CV-B4-infected thymuses ( n = 5–7), harvested at different time-points, was submitted to quantification of Aire , Fezf2 , Igf2, and Myo7 transcripts by qPCR. Transcripts levels were normalized to those of Oaz1. Relative gene expression in CV-B4 E2- vs. mock-infected thymuses was calculated, as described in , and expressed as 100 × mean 2 −ΔΔCt values ± SD. The unpaired t -test was used for statistical analysis. ** p < 0.01. Mock (●) mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Gene Expression
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens transcripts in enriched thymic epithelial cells. Whole thymuses were harvested, at different time-points, from offspring born to mock- and CV-B4-infected dams. Thymuses from fetuses or neonates of the same litter ( n = 5–12) were pooled and subjected to TECs isolation. Transcripts levels for Aire , Fezf2 , Igf2, and Myo7 , in enriched TECs, were determined by RT-qPCR and normalized to those of Oaz1. Relative gene expression in TECs from CV-B4 E2- vs. mock-infected thymuses was calculated, as described in , and expressed as 100 × mean 2 −ΔΔCt values ± SD. The unpaired t -test was used for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. Mock (●) TECs from mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): TECs from thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Isolation, Quantitative RT-PCR, Gene Expression
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens protein expression in the whole thymus. ( a ) Representative blots depicting the expression levels of AIRE, FEZF2, IGF2, and MYO7 proteins in CV-B4- and mock-infected thymus sampled at day 1. ( b ) Relative expression of AIRE, FEZF2, IGF2, and MYO7 determined by Western blot analysis. Proteins obtained from mock- and CV-B4-infected thymuses ( n = 3–5), harvested at different time-points, were submitted to AIRE, FEZF2, IGF2, and MYO7 quantification by Western-blot analysis. Proteins levels were normalized to those of VINCULIN used as a loading control. Relative protein levels in CV-B4 E2- vs. mock-infected thymuses are represented as mean ± SD. The unpaired t -test was used for statistical analysis. * p < 0.05. Mock (●): mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Expressing, Infection, Western Blot, Control
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Relationship between viral load and transcription factors, Aire ( a ) and Fezf2 ( b ), and autoantigens transcripts, Igf2 ( c ) and Myo7 ( d ), in the thymus. For each harvested thymus (CV-B4-infected or age-matched control), transcription factors and autoantigens transcripts together with the corresponding viral load were measured and plotted in the same graph. To better assess the effect of infection on transcription factors and autoantigens expression, an eventual correlation between both parameters was evaluated using the Spearmen’s correlation test. r is the Spearman’s correlation coefficient. p -values were corrected according to the Benjamini–Hochberg procedure ( P BH ). Thymuses harvested at day 17G (Day 17G (10G) (●)), day 1 (Day 1 (10G) (▲)) or day 5 (Day 5 (10G) (♦)) from mice born to dams inoculated (or mock) with CV-B4 at day 10 of gestation; thymuses harvested at day 1 (Day 1 (17G) (▼)) or day 5 (Day 5 (17G) (■)) from mice born to dams inoculated (or mock) with CV-B4 at day 17 of gestation. x and y axis were log-scaled.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Control, Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The primers and TaqMan probes of IGF, ER genes used for RT-PCR
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques:
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The mRNA levels of IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-3, ERα and ERβ in EAC, tumor-adjacent, and control groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Control
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The immunostaining of IGF-1R, IGF-2R, ERα and ERβ in EAC, atypical hyperplasia, and control groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Immunostaining, Control, Positive Control
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The relationship between the IGF and ER mRNA expression and clinico-pathological features of endometrioid adenocarcinoma
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The relationship between the IGF-1R, IGF2R, ERα and ERβ protein expression and clinico-pathological features of endometrioid adenocarcinoma
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: Correlation analysis of IGF and ER mRNA expression with clinico-pathological features of EAC
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: Correlation analysis of IGF-1R, IGF-2R, and ERα and ERβ protein expression with clinico-pathological features of EAC
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The analysis of the correlation between the mRNA expression of IGFs with ER subtypes in three groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing, Control
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: Schematic illustration of PTR-SeNPs and MUC1@PTR-SeNPs synthesis and their anti-tumor efficacy against human triple-negative breast cancer.
Article Snippet:
Techniques:
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: Structure characterization of PTR-SeNPs and MUC1@ PTR-SeNPs. Structure characterization of PTR-SeNPs by (A) TEM, (B) Zetasizer Nano ZS, (C, D) Nanosight NS300, (E1-4) HRTEM-EDS and (F, G) FT-IR. (H) Confirmation of MUC1-C + PTR-SeNPs conjugation by confocal microscopy after fluorescent labeling with anti-mouse IgG (H + L). (I, J) Characterization results of the particle size and potential of MUC1@PTR-SeNPs
Article Snippet:
Techniques: Conjugation Assay, Confocal Microscopy, Labeling
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: In vitro anti-tumor efficacy of PTR-SeNPs and MUC1@PTR-SeNPs on 17 TNBC c ell lines. ( A, B ) Protein expression level of MUC1 in 17 different TNBC cell lines. ( C, D ) IC 50 and maximum % growth inhibition of PTR-SeNPs and MUC1@PTR-SeNPs on 17 TNBC cell lines. ( E, G ) Cell cycle distribution triggered by PTR-SeNPs and MUC1@PTR-SeNPs in HCC1937 and MDA-MB-436 cells. After treatment with PTR-SeNPs or MUC1@PTR-SeNPs (4 and 40 μM) in HCC1937 and MDA-MB-436 cells for 72 h, cells were stained with propidium iodide followed by flow cytometry analysis using MultiCycle software. The apoptotic cell death was quantified by measuring the sub-G1 cell population. ( F, H ) Phosphatidylserine translocation mediated by PTR-SeNPs and MUC1@PTR-SeNPs in HCC1937 and MDA-MB-436 cells. After treatment with MUC1@PTR-SeNPs (4 and 40 μM) for 48 h, cells were co-stained with propidium iodide and Annexin-V-FITC followed by flow cytometry analysis [early apoptotic subset: Annexin V+/PI- (green); late apoptotic subset: Annexin V+/PT+ (red)].
Article Snippet:
Techniques: In Vitro, Expressing, Inhibition, Staining, Flow Cytometry, Software, Translocation Assay
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: In vivo anti-tumor efficacy of MUC1@PTR- SeNPs. (A) MUC1 mRNA expression in normal tissue and primary breast cancer tumor using GEPIA database. ( B ) MUC1 expression in tumor tissues of MDA-MB-468-bearing mice in preliminary study. (C – E) Dose-dependent study of tumor inhibition effect of MUC1@PTR-SeNPs [75 (Low), 375 (Mid) & 750 μg (High) Se/kg BW/day] on BALB/c nude mice transplanted with MDA-MB-468 xenograft after oral administration for 30 days. PTR-SeNPs (High; 750 μg Se/kg BW/day) was used to investigate the possible improvement of in vivo anti-tumor efficacy by the MUC1@PTR-SeNPs. Quantitative analysis of Se content (μg/g) in (F) blood and (G) tumor tissue of experimental mice. (H) H&E, Ki67 and Tunnel fluorescence staining of tumor sections to detect apoptosis in vivo . (I) Western blot analysis of PARP, p-Bcl-2, Bax and C-caspase-9 protein expression in tumor sections. (J) In the serum of each group of tumor-bearing mice, the results of blood biochemistry-related indexes were analyzed.
Article Snippet:
Techniques: In Vivo, Expressing, Inhibition, Fluorescence, Staining, Western Blot